Memorial Sloan Kettering Cancer Center

Commack, NY

Filters

Help Me Find Trials

Sort by

Accepting patients

Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission

Maintenance

Accepting patients

NUTRIVENTION-4

A Study of Health-Related Quality of Life in People With Multiple Myeloma Receiving Daratumumab or Lenalidomide

Monoclonal Antibody
CD38
Maintenance
Phase 2

Get personalized results in 60 seconds

All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.

Help me find trials

Accepting patients

REMOLD-MM

A Pilot Study of Romosozumab Efficacy and Safety for the Management of Myeloma-related OsteoLytic Disease in Postmenopausal Women With Multiple Myeloma and Osteoporosis (REMOLD-MM)

Sclerostin
Phase 1

Accepting patients

Talquetamab Consolidation After BCMA CAR-T

Talquetamab Consolidation After BCMA CART Cell Therapy for Relapsed or Refractory Multiple Myeloma

Bispecific Antibody
GPRC5D
Phase 2

Not yet accepting

MagnetisMM-30

A Phase 1B, Open-Label Study of Elranatamab in Combination with Iberdomide in Participants with Relapsed Refractory Multiple Myeloma

Bispecific Antibody
BCMA
CD3
Phase 1

Accepting patients

Isatuximab After Allogeneic Stem Cell Transplant

Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hematopoietic Cell Transplantation

Monoclonal Antibody
CD38
Phase 2

Accepting patients

Identifying Barriers to Cellular Therapy

Prospective Multi-Center Study to Identify Barriers to Cellular Therapies in Patients With Plasma Cell Disorders PROACT PCD

Observational Trial

Accepting patients

Genetic Studies

Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders